The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
The Interferon Regulatory Factor, IRF5, Is a Central Mediator of Toll-like Receptor 7 Signaling
Open accessAbstract
Interferon regulatory factors (IRFs) are critical components of virus-induced immune activation and type I interferon regulation. IRF3 and IRF7 are activated in response to a variety of viruses or after engagement of Toll-like receptor (TLR) 3 and TLR4 by double-stranded RNA and lipopolysaccharide, respectively. The activation of IRF5, is much more restricted. Here we show that in contrast to IRF3 and IRF7, IRF5 is not a target of the TLR3 signaling pathway but is activated by TLR7 or TLR8 signaling. We also demonstrate that MyD88, interleukin 1 receptor-associated kinase 1, and tumor necrosis factor receptor-associated factor 6 are required for the activation of IRF5 and IRF7 in the TLR7 signaling pathway. Moreover, ectopic expression of IRF5 enabled type I interferon production in response to TLR7 signaling, whereas knockdown of IRF5 by small interfering RNA reduced type I interferon induction in response to the TLR7 ligand, R-848. IRF5 and IRF7, therefore, emerge from these studies as critical mediators of TLR7 signaling.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The prominent therapeutic efficacy of unmodified mRNA is possibly due to activation of endosomal toll-like receptor 7/8 (TLR7/8) and subsequently causes pro-inflammatory cytokine secretion via MyD88-dependent IRF-5 phosphorylation (41).”
From mRNA vaccine with unmodified uridine induces robust type I interferon-dependent anti-tumor immunity in a melanoma model (2022) · cites this paper as [41]
Citations
Cites
Janeway, C. A., & Medzhitov, R. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.083001.084359 · Cited by 8,394
A Toll-like receptor recognizes bacterial DNA
Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., et al. (2000) · Nature · doi:10.1038/35047123 · Cited by 6,491
Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8
Heil, F., Hemmi, H., Hochrein, H., Ampenberger, F., Kirschning, C., Akira, S., Lipford, G., Wagner, H., & Bauer, S. (2004) · Science · doi:10.1126/science.1093620 · Cited by 3,947
Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA
Diebold, S. S., Kaisho, T., Hemmi, H., Akira, S., & Reis e Sousa, C. (2004) · Science · doi:10.1126/science.1093616 · Cited by 3,444
Role of Adaptor TRIF in the MyD88-Independent Toll-Like Receptor Signaling Pathway
Yamamoto, M., Sato, S., Hemmi, H., Hoshino, K., Kaisho, T., Sanjo, H., Takeuchi, O., Sugiyama, M., Okabe, M., Takeda, K., et al. (2003) · Science · doi:10.1126/science.1087262 · Cited by 3,286
IKKε and TBK1 are essential components of the IRF3 signaling pathway
Fitzgerald, K. A., McWhirter, S. M., Faia, K. L., Rowe, D. C., Latz, E., Golenbock, D. T., Coyle, A. J., Liao, S.-M., & Maniatis, T. (2003) · Nature Immunology · doi:10.1038/ni921 · Cited by 2,680
Small anti-viral compounds activate immune cells via the TLR7 MyD88–dependent signaling pathway
Hemmi, H., Kaisho, T., Takeuchi, O., Sato, S., Sanjo, H., Hoshino, K., Horiuchi, T., Tomizawa, H., Takeda, K., & Akira, S. (2002) · Nature Immunology · doi:10.1038/ni758 · Cited by 2,577
The Nature of the Principal Type 1 Interferon-Producing Cells in Human Blood
Siegal, F. P., Kadowaki, N., Shodell, M., Fitzgerald-Bocarsly, P. A., Shah, K., Ho, S., Antonenko, S., & Liu, Y.-J. (1999) · Science · doi:10.1126/science.284.5421.1835 · Cited by 2,293
Kadowaki, N., Ho, S., Antonenko, S., de Waal Malefyt, R., Kastelein, R. A., Bazan, F., & Liu, Y.-J. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.863 · Cited by 1,964
Recognition of single-stranded RNA viruses by Toll-like receptor 7
Lund, J. M., Alexopoulou, L., Sato, A., Karow, M. L., Adams, N. C., Gale, N. W., Iwasaki, A., & Flavell, R. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400937101 · Cited by 1,854
Triggering the Interferon Antiviral Response Through an IKK-Related Pathway
Sharma, S., tenOever, B. R., Grandvaux, N., Zhou, G., Lin, R., & Hiscott, J. B. (2003) · Science · doi:10.1126/science.1081315 · Cited by 1,685
Sato, M., Suemori, H., Hata, N., Asagiri, M., Ogasawara, K., Nakao, K., Nakaya, T., Katsuki, M., Noguchi, S., Tanaka, N., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)00053-4 · Cited by 1,342
TRAF6 is a signal transducer for interleukin-1
Cao, Z., Xiong, J., Takeuchi, M., Kurama, T., & Goeddel, D. V. (1996) · Nature · doi:10.1038/383443a0 · Cited by 1,305
Yamamoto, M., Sato, S., Mori, K., Hoshino, K., Takeuchi, O., Takeda, K., & Akira, S. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.12.6668 · Cited by 1,246
Oshiumi, H., Matsumoto, M., Funami, K., Akazawa, T., & Seya, T. (2003) · Nature Immunology · doi:10.1038/ni886 · Cited by 1,217
Toll-like Receptor 9–mediated Recognition of Herpes Simplex Virus-2 by Plasmacytoid Dendritic Cells
Lund, J. M., Sato, A., Akira, S., Medzhitov, R. M., & Iwasaki, A. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030162 · Cited by 1,197
LPS-TLR4 Signaling to IRF-3/7 and NF-κB Involves the Toll Adapters TRAM and TRIF
Fitzgerald, K. A., Rowe, D. C., Barnes, B. J., Caffrey, D. R., Visintin, A., Latz, E., Monks, B. G., Pitha, P. M., & Golenbock, D. T. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20031023 · Cited by 1,193
IRAK (Pelle) Family Member IRAK-2 and MyD88 as Proximal Mediators of IL-1 Signaling
Muzio, M., Ni, J., Feng, P., & Dixit, V. M. (1997) · Science · doi:10.1126/science.278.5343.1612 · Cited by 1,170
Kawai, T., Takeuchi, O., Fujita, T., Inoue, J., Mühlradt, P. F., Sato, S., Hoshino, K., & Akira, S. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.10.5887 · Cited by 1,115
Kawai, T., Sato, S., Ishii, K. J., Coban, C., Hemmi, H., Yamamoto, M., Terai, K., Matsuda, M., Inoue, J., Uematsu, S., et al. (2004) · Nature Immunology · doi:10.1038/ni1118 · Cited by 1,058
Yamamoto, M., Sato, S., Hemmi, H., Uematsu, S., Hoshino, K., Kaisho, T., Takeuchi, O., Takeda, K., & Akira, S. (2003) · Nature Immunology · doi:10.1038/ni986 · Cited by 1,052
Marié, I., Durbin, J. E., & Levy, D. E. (1998) · The EMBO Journal · doi:10.1093/emboj/17.22.6660 · Cited by 1,049
IRAK: A Kinase Associated with the Interleukin-1 Receptor
Cao, Z., Henzel, W. J., & Gao, X. (1996) · Science · doi:10.1126/science.271.5252.1128 · Cited by 898
IRF3 Mediates a TLR3/TLR4-Specific Antiviral Gene Program
Doyle, S. E., Vaidya, S. A., O’Connell, R. M., Dadgostar, H., Dempsey, P. W., Wu, T., Rao, G., Sun, R., Haberland, M. E., Modlin, R. L., et al. (2002) · Immunity · doi:10.1016/s1074-7613(02)00390-4 · Cited by 847
Yoneyama, M., Suhara, W., Fukuhara, Y., Fukuda, M., Nishida, E., & Fujita, T. (1998) · The EMBO Journal · doi:10.1093/emboj/17.4.1087 · Cited by 841
Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848
Jurk, M., Heil, F., Vollmer, J., Schetter, C., Krieg, A. M., Wagner, H., Lipford, G., & Bauer, S. (2002) · Nature Immunology · doi:10.1038/ni0602-499 · Cited by 838
Wathelet, M. G., Lin, C. H., Parekh, B. S., Ronco, L. V., Howley, P. M., & Maniatis, T. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80051-9 · Cited by 730
Sato, S., Sugiyama, M., Yamamoto, M., Watanabe, Y., Kawai, T., Takeda, K., & Akira, S. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.8.4304 · Cited by 730
Krug, A., French, A. R., Barchet, W., Fischer, J. A. A., Dzionek, A., Pingel, J. T., Orihuela, M. M., Akira, S., Yokoyama, W. M., & Colonna, M. (2004) · Immunity · doi:10.1016/j.immuni.2004.06.007 · Cited by 727
Krug, A., Luker, G. D., Barchet, W., Leib, D. A., Akira, S., & Colonna, M. (2003) · Blood · doi:10.1182/blood-2003-08-2674 · Cited by 696
NF‐κB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK‐related kinase
Pomerantz, J. L., & Baltimore, D. (1999) · The EMBO Journal · doi:10.1093/emboj/18.23.6694 · Cited by 599
McWhirter, S. M., Fitzgerald, K. A., Rosains, J., Rowe, D. C., Golenbock, D. T., & Maniatis, T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2237236100 · Cited by 542
Honda, K., Yanai, H., Mizutani, T., Negishi, H., Shimada, N., Suzuki, N., Ohba, Y., Takaoka, A., Yeh, W., & Taniguchi, T. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406933101 · Cited by 526
Three novel mammalian toll-like receptors: gene structure, expression, and evolution.
Du, X., Poltorak, A. N., Wei, Y., & Beutler, B. (2000) · PubMed · Cited by 460
Oshiumi, H., Sasai, M., Shida, K., Fujita, T., Matsumoto, M., & Seya, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305820200 · Cited by 413
Cloning and characterization of a sub-family of human toll-like receptors: hTLR7, hTLR8 and hTLR9.
Chuang, T., & Ulevitch, R. J. (2000) · PubMed · Cited by 399
Barnes, B. J., Moore, P. A., & Pitha, P. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101216200 · Cited by 388
Jiang, Z., Mak, T. W., Sen, G. C., & Li, X. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308496101 · Cited by 388
Au, W.-C., Moore, P. A., Lowther, W. J., Juang, Y., & Pitha, P. M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.25.11657 · Cited by 388
MEKK1 activates both IκB kinase α and IκB kinase β
Lee, F. S., Peters, R., Dang, L. C., & Maniatis, T. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9319 · Cited by 384
Bonnard, M., Mirtsos, C., Suzuki, S., Graham, K., Huang, J., Ng, M., Itié, A., Wakeham, A., Shahinian, A., Henzel, W. J., et al. (2000) · The EMBO Journal · doi:10.1093/emboj/19.18.4976 · Cited by 381
Gibson, S. J., Lindh, J. M., Riter, T. R., Gleason, R. M., Rogers, L. M., Fuller, A. E., Oesterich, J. L., Gorden, K. B., Qiu, X., McKane, S. W., et al. (2002) · Cellular Immunology · doi:10.1016/s0008-8749(02)00517-8 · Cited by 376
Imiquimod and the imidazoquinolones: mechanism of action and therapeutic potential
Stanley, M. (2002) · Clinical and Experimental Dermatology · doi:10.1046/j.1365-2230.2002.01151.x · Cited by 376
NAK is an IκB kinase-activating kinase
Tojima, Y., Fujimoto, A., Delhase, M., Chen, Y., Hatakeyama, S., Nakayama, K. I., Kaneko, Y. S., Nimura, Y., Motoyama, N., Ikeda, K., et al. (2000) · Nature · doi:10.1038/35008109 · Cited by 375
IKK-i, a novel lipopolysaccharide-inducible kinase that is related to IκB kinases
Shimada, T., Kawai, T., Takeda, K., Matsumoto, M., Inoue, J., Tatsumi, Y., Kanamaru, A., & Akira, S. (1999) · International Immunology · doi:10.1093/intimm/11.8.1357 · Cited by 369
Izaguirre, A. G., Barnes, B. J., Amrute, S. B., Yeow, W.-S., Megjugorac, N. J., Dai, J., Feng, D., Chung, E., Pitha, P. M., & Fitzgerald-Bocarsly, P. A. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0603255 · Cited by 346
IKKε Is Part of a Novel PMA-Inducible IκB Kinase Complex
Peters, R., Liao, S.-M., & Maniatis, T. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80445-1 · Cited by 335
Lin, R., Heylbroeck, C., Génin, P., Pitha, P., & Hiscott, J. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.2.959 · Cited by 325
Review: On the Role of IRF in Host Defense
Barnes, B. J., Lubyová, B., & Pitha, P. M. (2002) · Journal of Interferon & Cytokine Research · doi:10.1089/107999002753452665 · Cited by 318
Jiang, Z., Zamanian-Daryoush, M., Nie, H., Silva, A. M., Williams, B. R. G., & Li, X. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300562200 · Cited by 300
Au, W.-C., Moore, P. A., LaFleur, D. W., TOMBAL, B. F., & Pitha, P. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.44.29210 · Cited by 295
TANK, a co-inducer with TRAF2 of TNF- and CD 40L-mediated NF-kappaB activation.Preprint
Cheng, G., & Baltimore, D. (1996) · Genes & Development · doi:10.1101/gad.10.8.963 · Cited by 288
Juang, Y.-T., Lowther, W. J., Kellum, M. J., Au, W.-C., Lin, R., Hiscott, J. B., & Pitha, P. M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.17.9837 · Cited by 266
Cytokine induction by the immunomodulators imiquimod and S-27609
Testerman, T. L., Gerster, J. F., Imbertson, L. M., Reiter, M. J., Miller, R. L., Gibson, S. J., Wagner, T. L., & Tomai, M. A. (1995) · Journal of Leukocyte Biology · doi:10.1002/jlb.58.3.365 · Cited by 266
Li, X.-X., Commane, M., Burns, C., Vithalani, K. K., Cao, Z.-D., & Stark, G. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.7.4643 · Cited by 253
Barnes, B. J., Kellum, M. J., Field, A. E., & Pitha, P. M. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.16.5721-5740.2002 · Cited by 251
Global and Distinct Targets of IRF-5 and IRF-7 during Innate Response to Viral Infection
Barnes, B. J., Richards, J. O., Mancl, M. E., Hanash, S., Beretta, L., & Pitha, P. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400726200 · Cited by 223
Génin, P., Algarté-Génin, M., Roof, P., Lin, R., & Hiscott, J. B. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.10.5352 · Cited by 216
I-TRAF is a novel TRAF-interacting protein that regulates TRAF-mediated signal transduction.
Rothe, M., Xiong, J., Shu, H., Williamson, K., Goddard, A. D., & Goeddel, D. V. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8241 · Cited by 212
Review: Control of IRF-3 Activation by Phosphorylation
Yoneyama, M., Suhara, W., & Fujita, T. (2002) · Journal of Interferon & Cytokine Research · doi:10.1089/107999002753452674 · Cited by 158
Chariot, A., Leonardi, A., Müller, J. R., Bonif, M., Brown, K., & Siebenlist, U. K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205069200 · Cited by 157
Megyeri, K., Au, W.-C., ROSZTÓCZY, I., Raj, N. B. K., Miller, R. L., Tomai, M. A., & Pitha, P. M. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.4.2207 · Cited by 136
Barnes, B. J., Field, A. E., & Pitha-Rowe, P. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212609200 · Cited by 119
Management of anogenital warts (condylomata acuminata).
von Krogh, G. (2001) · PubMed · Cited by 105
NF‐κB activation through IKK‐i‐dependent I‐TRAF/TANK phosphorylation
Nomura, Kawai, T., Nakanishi, K., & Akira, S. (2000) · Genes to Cells · doi:10.1046/j.1365-2443.2000.00315.x · Cited by 102
Yeow, W.-S., Au, W.-C., Juang, Y., Fields, C. D., Dent, C. L., Gewert, D. R., & Pitha, P. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.9.6313 · Cited by 98
High IL-13 production by human neonatal T cells: neonate immune system regulator?
Ribeiro-do-Couto, L. M., Boeije, L. C. M., Kroon, J., Hooibrink, B., Breur-Vriesendorp, B. S., Aarden, L. A., & Boog, C. J. P. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200111)31:11 · Cited by 91
Automated, quantitative cytopathic effect reduction assay for interferon
Yeh, T. J., McBride, P. T., Overall, J. C., & Green, J. A. (1982) · Journal of Clinical Microbiology · doi:10.1128/jcm.16.2.413-415.1982 · Cited by 56
Reich, N. C. (2002) · Journal of Interferon & Cytokine Research · doi:10.1089/107999002753452719 · Cited by 48
IL-1R-Associated Kinase 4 Is Required for Lipopolysaccharide- Induced Activation of APC
Suzuki, N., Suzuki, S., Eriksson, U., Hara, H., Mirtosis, C., Chen, N., Wada, T., Bouchard, D., Hwang, I. I. L., Takeda, K., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.11.6065 · Cited by 40
Mechanisms of human beta-interferon gene regulation.
Maniatis, T. (1988) · PubMed · Cited by 24
Dent, C. L., & Gewert, D. R. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.t01-1-00895.x · Cited by 12
Flagged first, then by citations
Research works printed but not linked: 4
- Chuang, 2000, Eur. Cytokine Netw., 11, 372
- Du, 2000, Eur. Cytokine Netw., 11, 362
- von Krogh, 2001, Eur. J. Dermatol., 11, 598
- Maniatis, 1986, Harvey Lect., 82, 71
Cited by
Sorted by citations
Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses
Mogensen, T. H. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00046-08 · Cited by 3,296
Toll-like Receptors and the Control of Immunity
Fitzgerald, K. A., & Kagan, J. C. (2020) · Cell · doi:10.1016/j.cell.2020.02.041 · Cited by 2,168
Innate immune recognition of viral infection
Kawai, T., & Akira, S. (2006) · Nature Immunology · doi:10.1038/ni1303 · Cited by 1,899
Kawai, T., & Akira, S. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401850 · Cited by 1,894
Honda, K., & Taniguchi, T. (2006) · Nature reviews. Immunology · doi:10.1038/nri1900 · Cited by 1,716
Metadata
- Authors
- Schoenemeyer, A., Barnes, B. J., Mancl, M. E., Latz, E., Goutagny, N., Pitha, P. M., Fitzgerald, K. A., & Golenbock, D. T.
- Affiliations
- University of Massachusetts Chan Medical School (US)
- Johns Hopkins University (US)
- Corresponding author
- Fitzgerald, Katherine A.
- Golenbock, Douglas T.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2005-04
- Volume
- 280
- Issue
- 17
- Pages
- 17005-17012
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2040706148
- Cited by
- 411
- References
- 72
- Citations by year
- 2026: 7 · 2025: 8 · 2024: 16 · 2023: 16 · 2022: 11 · 2021: 13 · 2020: 16 · 2019: 21 · 2018: 23 · 2017: 25 · 2016: 11 · 2015: 14 · 2014: 25 · 2013: 17 · 2012: 20
- FWCI
- 11.11
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- eScholarship@UMassChan (submittedVersion)
- Funders
- National Cancer Institute (R01A1/CA19737-19A1)
- National Institute of General Medical Sciences (GM 54060)
- National Institute of Allergy and Infectious Diseases (AI-52455, AI 49309, R01AI049309)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- IRF5, IRF7, TLR7, TLR8, TLR7 signaling, type I interferon, MyD88, TRAF6, IRAK1, IRF3, interferon regulatory factors, R848, innate immunity
- MeSH terms
- Antigens, Differentiation, Biological Assay, Cell Line, DNA-Binding Proteins, Dose-Response Relationship, Drug, Glutathione Transferase, Humans, Interferon Type I, Ligands, Lipopolysaccharides, Membrane Glycoproteins, Models, Biological, Phosphorylation, Receptors, Cell Surface, Receptors, Immunologic, Recombinant Fusion Proteins, RNA, Double-Stranded, Time Factors, Transcription Factors, Transfection, Signal Transduction, Genes, Reporter, Electroporation, Microscopy, Confocal, Reverse Transcriptase Polymerase Chain Reaction, RNA Interference, RNA, Small Interfering, Adaptor Proteins, Signal Transducing, Interferon Regulatory Factors, Interferon Regulatory Factor-3, Interferon Regulatory Factor-7, Toll-Like Receptors, Toll-Like Receptor 3, Toll-Like Receptor 4, Toll-Like Receptor 7, Toll-Like Receptor 8, Myeloid Differentiation Factor 88
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review